A number of firms have modified their ratings and price targets on shares of Halozyme Therapeutics (NASDAQ: HALO) recently: 11/19/2025 – Halozyme Therapeutics had its “buy (b)” rating reaffirmed by analysts at Weiss Ratings. 11/18/2025 – Halozyme Therapeutics had its price target raised by analysts at The Goldman Sachs Group, Inc. from $54.00 to $56.00. […]

Trade Desk (NASDAQ: TTD) has recently received a number of price target changes and ratings updates: 11/25/2025 – Trade Desk had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings. 11/19/2025 – Trade Desk had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings. 11/13/2025 – Trade Desk had its “hold (c-)” rating […]

Papa John’s International (NASDAQ: PZZA) has recently received a number of price target changes and ratings updates: 11/24/2025 – Papa John’s International had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings. 11/17/2025 – Papa John’s International had its “hold (c-)” rating reaffirmed by analysts at Weiss Ratings. 11/10/2025 – Papa John’s International had […]

PTC Therapeutics (NASDAQ: PTCT) recently received a number of ratings updates from brokerages and research firms: 11/25/2025 – PTC Therapeutics had its “hold (c)” rating reaffirmed by analysts at Weiss Ratings. 11/19/2025 – PTC Therapeutics had its “hold (c)” rating reaffirmed by analysts at Weiss Ratings. 11/13/2025 – PTC Therapeutics had its “hold (c)” rating […]